TITLE:
Phase 2 Study of TLK286 in Metastatic Breast Cancer

CONDITION:
Breast Neoplasms

INTERVENTION:
TLK286

SUMMARY:

      The purpose of this study is to determine the effectiveness of TLK286 in treatment of
      metastatic breast cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologic diagnosis of breast cancer

          -  Metastatic disease

          -  Measurable or evaluable disease

          -  No prior chemotherapy regimens

          -  Age at least 18 years

          -  Adequate liver and kidney function

          -  Adequate bone marrow function

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Unstable medical conditions

          -  Chemotherapy within 14 days of TLK286

          -  Radiation therapy within 14 days of TLK286

          -  Hormonal therapy within 14 days of TLK286

          -  Immunotherapy within 14 days of TLK286

          -  CNS metastasis unless controlled by treatment
      
